Front Cell Dev Biol May 2023 PMID 37305682

Merits and challenges of iPSC-derived organoids for clinical applications.

Ziran Xu, Jiaxu Yang, Xianyi Xin, Chengrun Liu, Lisha Li, Xianglin Mei, Meiying Li

Download social card

Mentions

2
Peak: 1 in May 2023
across 2 sources since May 2023

Extended reach

3,832
potential audience

Total likes

1

Video views

29

Mentions per month

May 2023 – Aug 2023

Where it's discussed

  • X / Twitter1 posts
  • YouTube1 videos

AI synopsis

What people are saying

The overall tone of the discussions reflects excitement and acknowledgment of the importance of iPSC-derived organoids, with comments analyzing their potential in disease modeling and therapy. Words like 'unprecedented,' 'critical,' and 'revolutionize' suggest optimism, while mentioning challenges indicates an understanding of current limitations, demonstrating moderate engagement and high interest in future developments.

AgreementModerate agreement

Most discussions acknowledge the significance of iPSC-derived organoids in medical research, reflecting a general consensus on their potential.

InterestHigh interest

The conversations highlight strong curiosity about advancements and applications, indicating high interest from participants.

EngagementModerate engagement

Many posts delve into specific challenges and future implications, showing moderate to deep involvement with the topic.

ImpactModerate impact

Participants seem to recognize that overcoming current hurdles could greatly influence regenerative medicine and disease modeling, hence a positive impact perception.

Abstract in brief

  • Induced pluripotent stem cells (iPSCs) have advanced significantly and are now crucial for disease modeling, drug development, and regenerative medicine, especially when combined with 3D organoid culture systems that mimic true organ structure and function.
  • Organoids derived from iPSCs can model organ development, regeneration, and disease processes, providing insights into biological regulation and pathological mechanisms, including applications in COVID-19 treatment.
  • Despite their potential, there are still unresolved challenges and limitations in using iPSC-derived organoids for clinical applications, which need addressing to fully realize their therapeutic benefits.]

Top posts

Most liked on X and Bluesky
Frontiers - Cell Biology
@FrontCellDevBio · X

New Research: Merits and challenges of iPSC-derived organoids for clinical applications: Induced pluripotent stem cells (iPSCs) have entered an unprecedented state of development since they were first generated. They have played a critical… #celldevbio https://t.co/BeuRhVYbKe

May 26, 2023 · 3,804 followers View post →

All mentions

Frontiers - Cell Biology
@FrontCellDevBio · X

New Research: Merits and challenges of iPSC-derived organoids for clinical applications: Induced pluripotent stem cells (iPSCs) have entered an unprecedented state of development since they were first generated. They have played a critical… #celldevbio https://t.co/BeuRhVYbKe

May 26, 2023 · 3,804 followers View post →